All In MedTech

Company

Natera

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements.

Public

Listed

NTRA

Nasdaq · Natera, Inc.

Public float

$21.8B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$2.31B

Fiscal year ending Dec 31, 2025

Net income

-$208M

Fiscal year ending Dec 31, 2025

R&D spending

$624M

Fiscal year ending Dec 31, 2025

Cash

$1.10B

As of Sep 30, 2026

Long-term debt

Not reported

Shares outstanding

145.0M

As of Oct 31, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2023$235M–––
2022$433M–––
2021$551M––$278M

Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

Investors

5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

The investor database is part of the paid tier

For Natera we have 4 shareholders with 5% or more.

It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

Latest FDA decisions

Search the Clearance Tracker

Device trials

Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

Open in the Trial Radar

4 more trials with a free account

Reports received

0

Received Nov 1, 2025 to Nov 20, 2026

Malfunction reports

0

Injury reports

0

Death reports

0

Adverse event reports received per month

Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

Search the MAUDE Monitor

No reports to chart for this view.

Device types named most often

Last 12 months, by FDA product code. A company that sells more gets more reports.

No device types to rank.

Brand names named most often

Last 12 months, as written on the reports. One product can appear under several spellings.

No brand names to rank.

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

No recalls under this name in FDA's data.

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.